摘要 |
Compounds of the Formula (I) and pharmaceutically acceptable salts thereof, wherein X<SUB>1</SUB>, X<SUB>2</SUB>, X<SUB>3</SUB>, X<SUB>4</SUB>, X<SUB>5</SUB>, X<SUB>6</SUB>, X<SUB>7</SUB>, R<SUP>1</SUP>, and Q<SUP>1</SUP> are defined herein, inhibit protein kinase enzymes and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system. |
申请人 |
OSI PHARMACEUTICALS, INC.;CREW, ANDREW, PHILIP;DONG, HAN-QING;MULVIHILL, MARK, JOSEPH;WERNER, DOUGLAS, S.;KADALBAJOO, MRIDULA;LAUFER, RADOSLAW |
发明人 |
CREW, ANDREW, PHILIP;DONG, HAN-QING;MULVIHILL, MARK, JOSEPH;WERNER, DOUGLAS, S.;KADALBAJOO, MRIDULA;LAUFER, RADOSLAW |